KRT17 and COVID-19: In addition, although our machine learning–based transcriptomics analysis supports the use of KRT17+KRT5− basaloid cells or profibrotic alveolar macrophages in bronchoscopic biopsies as markers of irreversible lung disease in patients with severe COVID-19, further clinical studies are necessary to validate these findings.